Stage-dependent activation of cell cycle and apoptosis mechanisms in the right ventricle by pressure overload  by Ecarnot-Laubriet, A. et al.
Stage-dependent activation of cell cycle and apoptosis mechanisms in
the right ventricle by pressure overload
A. Ecarnot-Laubriet a, M. Assem a, F. Poirson-Bichat b, M. Moisant c, C. Bernard c,
S. Lecour a, E. Solary b, L. Rochette a, J.-R. Teyssier a;d;
a Laboratory of Experimental Cardiovascular Physiopathology, 7 Boulevard Jeanne d’Arc, 21033 Dijon, France
b INSERM U 517, Faculty of Medicine, 7 Boulevard Jeanne d’Arc, 21033 Dijon, France
c Laboratory of Histology, 7 Boulevard Jeanne d’Arc, 21033 Dijon, France
d Laboratory of Molecular Genetics, IFR 100, Faculty of Medicine, 7 Boulevard Jeanne d’Arc, 21033 Dijon, France
Received 30 July 2001; received in revised form 19 October 2001; accepted 9 November 2001
Abstract
The molecular basis of the intrinsic vulnerability of the compliant right ventricle to chronic pressure overload is poorly
understood. Extensive apoptosis, possibly coupled with aberrant cell cycle reentry, in response to unrestrained
biomechanical stress may account for this phenotypic flaw. To address this issue we have studied changes in expression
of the cell cycle and apoptosis regulators in the right ventricle following induction of pulmonary hypertension in the rat by
injection of monocrotaline. Hypertrophy, apoptosis and cell cycle events, as well as expression of their regulator genes were
documented during a period of 31 days. The hypertrophy index reached 127% at day 31. At the early stage both apoptosis
and cell proliferation pathways were coincidentally activated. The level of cyclin A and E transcripts steadily increased, the
labeling index was 4.8% at day 31, and expression of the caspase-3 gene peaked at day 14. Until day 21 execution of
apoptosis was prevented, probably by a high level of Bcl-2. At this time point Bcl-2 collapsed, cyclin D1 was upregulated,
the differentiation gatekeeper p27Kip1 was downregulated, pro-caspase-3 was activated and extensive apoptosis developed.
These results indicate that the right ventricle is especially vulnerable to apoptotic pressure-dependent stimuli, and that the
cell cycle and apoptosis pathways were co-activated in this experimental model. ß 2002 Elsevier Science B.V. All rights
reserved.
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1. Introduction
It is well recognized that the thin, compliant wall
of the right ventricle (RV) responds to pressure over-
load by insu⁄cient tension control and massive dila-
tation. In human this intrinsic defect is responsible
for the chronic ‘cor pulmone’ syndrome in patients
with pulmonary hypertension, which ends with clin-
ically intractable deterioration of the right ventricular
functions. This syndrome a¡ects 40% of people dying
from chronic obstructive pulmonary disease [1]. The
molecular basis of this biomechanical £aw remains
poorly understood, but experimental results in pigs
provided evidence that elevated pressure causes early,
irreversible, deleterious cellular changes in the
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stretch-responsive RV cardiomyocytes: RV dysfunc-
tion persists at recovery after restoration of normal
pressure, and the severity of this post-relief dysfunc-
tion is directly correlated with the degree of the acute
wall stress [2]. We have recently demonstrated that in
rats with chronic pulmonary hypertension, there is a
pressure-induced reversion of the cardiomyocyte phe-
notype to the fetal stage (the so-called phenoconver-
sion), resulting in the downregulation and nuclear
relocation of a critical cytoskeletal stress protein,
which contributes to the progressive deterioration
of the RV mechanical resistance and is associated
with ¢brillar disarray [3]. We hypothesized that the
retro-di¡erentiating stimuli may also be involved in
this deterioration of the RV myocardium by causing
apoptotic cell loss, possibly in response to aberrant
cell cycle reentry. To test this hypothesis we have
studied the chronology of changes in the expression
of the major genes regulating apoptosis: (p53, Bcl-2,
Bax, Fas/CD95, caspase-3), and cell cycle progression
(cyclin A, cyclin E, cyclin D1, p21Cip1, p27Kip1), in
a rat model of pressure-induced right ventricular hy-
pertrophy (RVH), which mimics the functional
changes observed in the human ‘cor pulmone’ syn-
drome [4]. The mRNA level of the type 1 receptor
(AT1) to angiotensin II (AngII) was also measured
because in vitro results suggest that locally produced
AngII may be a direct mediator in both stretch-acti-
vated cell death and cell growth, through upregula-
tion of AT1 [5].
2. Material and methods
2.1. Induction and determination of right ventricular
hypertrophy
The induction of right ventricular hypertrophy by
intraperitoneal injection of the pyrrolizidine alkaloid
monocrotaline (MCT) (60 mg per kg) in Wistar rats,
and the determination of the increased right ventric-
ular pressures and hypertrophic index at days 7, 14,
21, and 31 after injection have been carried out ex-
actly as previously reported [3].
2.2. Immunohistochemistry and TUNEL
At each time point two control and two treated
rats were injected with 50 mg per kg of BrdU (Sig-
ma-Aldrich, France) and sacri¢ced 24 h later. The
midregion of the hearts was cut perpendicularly to
the major axis, ¢xed in bu¡ered formalin, embedded
in para⁄n, then cut in 4^6 Wm sections which were
labeled by the immunoperoxidase technique previ-
ously described [3]. The slides were exposed to
speci¢c antibodies which recognize the following
molecules: BrdU (M 774): 1:50 (Dako, LSAB, Den-
mark); Bax (Ab-1) and Bcl-2 (Ab-2): 1:100 (Calbio-
chem, USA); p53 (FL-393): 1:100, p21 (F-5): 1:200,
p27 (F-8): 1:500, Fas (M-20): 1:200 (Santa Cruz
Biotechnology, USA); cyclin A (Ab-1), cyclin E
(Ab-1) and cyclin D1 (Ab-1): 1:100, (Neomarkers,
USA). Positive and negative human pathological
samples (normal and cancerous tissues) were used
as controls. Primary antibodies were omitted in par-
allel blank reactions. The apoptosis associated chro-
matin fragmentation has been detected by the Apop-
tag in situ detection kit (Oncor, USA) following the
manufacturer’s instructions. The scores of the nu-
clear localized markers were expressed as the per-
centage of positive stained nuclei identi¢ed following
examination of about 1000 nuclei in each of the pro-
cessed RV and left ventricle (LV). The myocyte nu-
clei were identi¢ed by the standard morphological
criterion: typical ovoid nucleus included in the
cross-striated cytoplasm of myocardial ¢bers in
transversally oriented section.
2.3. DNA laddering
At days 14, 21, 31 the genomic DNA was ex-
tracted from two entire RV and LV free walls
(200^500 mg) by the routine proteinase K-phenol-
chloroform technique and treated by RNase A at
37‡C for 1 h. Twenty micrograms of each of the 12
DNA samples were loaded onto an ethidium bro-
mide stained agarose gel (1.4%), electrophoresed
and observed under UV light.
2.4. Caspase-3 activity assay
The catalytic activity of caspase-3 was measured
by £uorometry, using the ApoAlert Caspase Assay
Kit (Clontech, USA) and the speci¢c caspase-3 £uo-
rogenic substrate II (DEVD-AMC, Calbiochem,
USA). Brie£y, at each time point 50 Wl of cell lysate
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extracted from four control and four MCT-treated
rats RV were incubated with 10 Wl of substrate in the
reaction bu¡er. The enzyme-catalyzed cleavage reac-
tion was monitored by measuring during 15 min the
£uorescence produced by the released AMC mole-
cule at 460 nm (excitation: 380 nm), using a SFM
25 spectro£uorometer (Kontron Instruments, Swit-
zerland). The caspase-3 activity was expressed in ar-
bitrary units as the mean of the following ratios:
slope of the £uorescent curve/protein content of the
myocardium lysate (in mg).
2.5. Quanti¢cation of gene transcripts by RT-PCR
The steady state level of the studied gene tran-
scripts has been evaluated by a comparative RT-
PCR assay using a L-actin sequence internal stan-
dard as previously described [3,6]. The mRNA level
of atrial natriuretic factor (ANF) was measured be-
cause overexpression is the hallmark of the ‘rever-
sion’ to the fetal genetic program under mechanical
overload [7]. The sequence and location of primers,
the size of amplicons, and the speci¢c cycling
parameters are given in Table 1. Densitometric quan-
ti¢cation of £uorescent signals was performed by
the image analyzer Gel Doc1000 system driven by
the Molecular Analyst software (Bio-Rad, USA).
The PCR ampli¢cation yield was expressed in arbi-
trary units (AU) as the ratio of the target/L-actin
amplicon optical densities. At each experimental
time point the results obtained in control and
MCT-treated rats were expressed as the mean þ S.D.
of 24 densitometric readings recorded from four
PCR products, sampled during the exponential phase
of two independent ampli¢cation reactions, carried
out in the six RV and six LV samples. The
data were compared by the variance analysis test
(ANOVA).
Table 1
Primer sequences and PCR conditions
Nt AP ‡C NC
P53 (F)GTCATCTTCCGTCCCTTCTCA 273^293 300 55 28
(R)TGTGCCGAAAAGTCTGCCTGT 617^637
P21 (F)GCCCGTGAGCGATGGAACTT 133^152 200 60 30
(R)ATGCTGGTCTGCCGCCGTTT 421^440
P27 (F)TAGCCTGGAGCGGATGGACG 33^52 200 58 28
(R)GCATTTGGGGAACCGTCTGA 523^542
L-Actin (F)TTGTAACCAACTGGGACGATATGG 224^247 35 60 28
(R)GATCTTGATCTTCATGGTGCTAGG 964^988
ANF (F)TATTGGAGCAAATCCCGTAT 127^146 200 60 26
(R)TTTGGCTGTTATCTTCGGTA 512^531
Fas (F)CAGCCTGGTGAACGAAAAGT 165^184 200 60 32
(R)CGGCAGTTCTCCAGATGTAT 715^734
Bax (F)GCTTCAGGGTTTCATCCAGG 78^107 200 60 28
(R)GAAGTCCAATGTCCAGCCCA 410^429
BCl-2 (F)CACCCCTGGCATCTTCTCCTTC 142^153 400 60 30
(R)TAGTTCCACAAAGGCATCCCAG 573^594
AngIIR (F)CTGGCAGGCACAGTTACATA 321^340 200 55 30
(R)AGGGAACAAGAAGCCCAGAA 861^880
Cyclin A (F)CGTGGACTGGTTAGTTGA 749^766 200 55 32
(R)ATGGCAAATACTTGAGGT 1147^1164
Cyclin D (F)GATGAAGCAGACCATTCCCT 461^479 200 50 30
(R)CTGCTTGTTCTCATCCGC 636^654
Cyclin E (F)GAAAATCAGACCGCCCAGAG 474^493 200 60 30
(R)CGGAGCAAGCACCATCAGTA 837^856
Caspase-3 (F)GCCGACTTCCTGTATGCTTA 597^616 200 55 28
(R)GCAGGCAGTGGTATTGTTCA 1007^1026
F, forward; R, reverse; Nt, nucleotide localizations; AP, amount of primers (ng); ‡C, annealing temperature; NC, number of PCR
cycles.
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2.6. In situ hybridization (ISH)
Because the myocardium is a heterogeneous tissue
the transcripts have been localized at the cellular
level by ISH using the PCR fragments as labeled
probes. The speci¢city of these fragments has been
checked previously by restriction mapping (restric-
tion sites at http://www.infobiogen.fr). The frag-
ments were labeled by adding 2 Wl of dATP biotin
(Gibco BRL, France) to the PCR reaction mix. The
fragments were puri¢ed from agarose gel by the Gen-
Elute spin column (Sigma-Aldrich Chimie, France).
Five microliters of the eluted DNA were added to 15
Wl of the in situ hybridization solution (Dako,
France) and dropped onto tissue section. The for-
malin ¢xed sections had been previously depara⁄-
nized, pretreated with a 0.4% pepsin solution (Sig-
ma-Aldrich Chimie) for 15 min at room temperature,
washed in sterile water and dried. For hybridization
the slides were incubated at 80‡C for 10 min then at
40‡C overnight. Following stringent washing the
slides were incubated with alkaline phosphatase-con-
jugated rabbit anti-biotin antibody (1/500, Dako)
and the hybridization signal was revealed by the
ready-to-use Fast BCIP/NBT chromogen solution
(Sigma-Aldrich Chimie). Sections were counter-
stained by nuclear fast red. Slides pretreated with
RNase were used as control. The mRNAs have
been localized by ISH in the ventricular tissues ex-
pressing the highest steady state levels measured by
RT-PCR (cyclin E and p21: day 31; Bcl-2: day 14;
cyclins A and D1, p53 and caspase-3: day 21).
3. Results
The chronology of changes in the RV mRNA con-
tent disclosed three distinct patterns: (i) incremental
(ANF, p21, cyclin A and cyclin E), (ii) decremental
(Bax and p27), and (iii) biphasic (caspase-3, p53, Bcl-
2, and cyclin D1) (Fig. 1).
3.1. The cell cycle and apoptosis genes were
coactivated by pressure overload
The increase of the ANF RNA level 2 and 4 times
over the basal values at days 14^21 and 31, res-
pectively, attested that expression of the ANF gene
has been reactivated by the pressure-induced wall
stress [3]. Concomitantly there was a 6^8-fold
increase in the content of the S activating cyclins
(cyclin A and cyclin E) RNA from day 14 to day
31. These changes were associated with a 2^2.7-fold
decrease in the RNA levels of the cyclin-dependent
kinase inhibitor (CDKI) p27, indicating that the
di¡erentiation-dependent cell cycle block had been
overridden. This was followed by upregulation of
the other CDKI p21 at day 31 (Fig. 1A). The reentry
of cardiomyocytes into S phase was con¢rmed by a
BrdU labeling index, 7- and 18-fold higher in the
overloaded (day 14) and failing (day 31) ventricles
than in the control hearts (Table 2). Signi¢cantly,
the genes which positively and negatively control
apoptosis were also coordinately activated, at the
early stage of hypertrophic growth: at day 14 the
anti-apoptotic Bcl-2 gene was highly expressed
(150% of the control) and the transcript level of the
pro-apoptotic caspase-3 gene was increased by 40%
(Fig. 1B).
Table 2
Fraction of immunolabeled myocytes (n = 2000)
% of labeled cells
Controls Day 14 Day 21 Day 31
P21 ND ND 12 28.4
P27 31.7 29.5 14.6 9.2
Cyclin D1 ND ND 2.3 7.5
Cyclin A ND ND 1 6.6
Cyclin E ND ND 0.8 5.7
BrdU 0.27 1.8 2.7 4.8
TUNEL ND ND 1.7 2.9
ND, not detected.
C
Fig. 1. Quanti¢cation of the steady state levels of the mRNAs (n = 24) and of the caspase-3 activity (n = 8) in the right ventricular my-
ocardium during the hypertrophic process (open bars, controls; solid bars, MCT rats). Values are means þ S.E.M. of AU. *P6 0.05,
**P6 0.01 and ***P6 0.001 vs. control. RNA level of the genes controlling cell cycle (A) and apoptosis (B). Values of the AngIIR
and Fas mRNA levels which did not vary are not shown.
BBADIS 62084 26-4-02 Cyaan Magenta Geel Zwart
A. Ecarnot-Laubriet et al. / Biochimica et Biophysica Acta 1586 (2002) 233^242236
BBADIS 62084 26-4-02 Cyaan Magenta Geel Zwart
A. Ecarnot-Laubriet et al. / Biochimica et Biophysica Acta 1586 (2002) 233^242 237
3.2. Delayed execution of apoptosis coincided with a
drop in Bcl-2 and upregulation of cyclin D1
Accumulation of TUNEL positive nuclei was de-
tected from day 21, ¢rst in the epicardial and endo-
cardial regions, then across the entire ventricular wall
at day 31 (Table 2). Consistently a DNA laddering
indicative of internucleosomal fragmentation was
Fig. 2. Examples of cell labeling (A,B) and DNA ladder (C). (A) Immunohistochemistry. Cytoplasmic labeling of the RV myocardium
by anti-Bcl-2 antibody in a MCT rat at day 14 (left) and day 31 (right). (B) Myocyte nuclei expressing the cyclin A protein in a con-
trol rat (left) and in a MCT rat at day 31 (right). (C) Myocyte nuclei labeled by anti-p27 antibody in a control rat (left) and a MCT
rat at day 31 (right). (B) In situ hybridization. Twin histological sections from a serially cut RV myocardium of a MCT rat at day
21. (Upper) Standard histological staining showing the cardiomyocytes (arrowhead) and the perivascular and interstitial ¢brosis (ar-
row). (Lower) In situ hybridization signal produced by the probe for cyclin A. Magni¢cation U700 shows that the probe gave a ho-
mogeneous brown signal in the cytoplasm of cardiocytes (arrowhead) and that the connective tissue was negative (arrow). (C) Electro-
phoretic pattern of DNA extracted from the RV free wall of a control rat (lane C) and of MCT rats sacri¢ced at day 14 (lane D14),
day 21 (lane D21), and day 31 (lane D31). Lane MW, 100 bp molecular weight marker.
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evident at days 21 and 31 (Fig. 2C). Execution of the
apoptotic program was attested by the activity of the
e¡ector caspase-3 which increased by 150% at day 21
before paradoxically returning to the control level at
day 31 (Fig. 1B). In agreement with previous results
[8] the cell death process itself was associated with a
downregulation of caspase gene expression (Fig. 1B).
The progression of apoptosis coincided with a dra-
matic 4-fold decrease in the Bcl-2 mRNA level and
with a more limited reduction of the Bax transcripts
(Fig. 1B). The consequence of these variations was
an inversion of the Bcl-2/Bax ratio which decreased
from 1.2 at day 14 to 0.7 at day 21, and 0.3 at day
31. At the same time expression of the cyclin D1 gene
was markedly upregulated by a factor of ¢ve at day
21 (Fig. 1A).
The transcripts quanti¢ed by RT-PCR were selec-
tively identi¢ed by ISH in the cytoplasm of RV car-
diomyocytes and were detected neither in the vessel
walls, nor in the interstitial ¢brous tissue of the RV
(Fig. 2B). Cardiomyocytes of the whole RV myocar-
dium were heavily labeled by probes for cyclins and
caspase-3, but those for Bcl-2 and p21 produced
weaker signals. The results of the immunohistochem-
istry showed that signi¢cant changes in protein ex-
pression consistently occurred at day 21 and were
accentuated at day 31 (Table 2 and examples in
Fig. 2A). A positive immunoreaction with antibodies
for p21 was observed at day 21, and the fraction of
labeled nuclei increased twice from day 21 to day 31.
On the contrary the number of anti-p27 reactive cells
decreased by 50% and 72% at day 21 and 31, respec-
tively. Accumulation of cyclin A/E transcripts de-
tected from day 14 was followed by a 6-fold increase
in the number of protein expressing nuclei from day
21 to day 31. During the same period the percentage
of nuclei reacting with anti-cyclin D1 antibody be-
came more than 3 times higher. Strong and weak
cytoplasmic signals were produced by antibodies
for Bcl-2 at day 14 and 31, respectively, but Bax
antibodies gave negative results. We have comple-
mented this study by determining the levels of the
ANF, cyclin A, cyclin E, caspase-3, and Bcl-2 tran-
scripts at day 7: they were similar in the MCT-
treated and matched control rats (results not shown).
Finally no signi¢cant changes in the mRNA levels or
in the percentages of immunolabeled cells have been
detected in the LV.
3.3. The AT1-p53-Fas pathway was not activated in
this model
The AT1 and Fas mRNA levels remained stable
(results not shown). The steady state levels of the p53
RNA showed a transient peak at day 21 before re-
turning to baseline (Fig. 1B). Immunochemistry
failed to detect the p53 or Fas protein.
4. Discussion
In the same series of rats used in this study we
have previously reported that MCT caused a signi¢-
cant increase in lung weight from day 14 which was
followed by a steady increase in the right ventricle
hypertrophic index (40% and 126% at days 21 and
31, respectively) and intrachamber pressures, leading
to life threatening cardiac failure at day 31 [3]. The
¢rst sign of the adaptive response to elevated work-
load was an increase in the mRNA levels of ¢ve
genes including ANF, which occurred at day 14, be-
fore any anatomical evidence of heart hypertrophy.
The level of ANF is quantitatively related to the
degree of the hemodynamic load, and upregulation
of ANF is the hallmark of the stress-induced re-ex-
pression of the ‘fetal gene program’ [7]. Our results
have shown that at this time four other developmen-
tally regulated genes involved in the regulation of
apoptosis (pro-caspase-3 and Bcl-2) and in the pro-
gression of embryonic and neonatal cardiomyocytes
through S phase (cyclin A and cyclin E) [9^12] were
precociously and coincidentally activated. In addi-
tion, the S phase labeling index of about 5% at day
31 was similar to that detected in neonatal cardiac
myocytes [10,12]. Together these data attest that the
pre-adult hyperplastic growth mechanisms were reac-
tivated in the RV by pressure overload. Marked up-
regulation of the S-related cyclins (A and E) and the
resulting initiation of DNA synthesis at day 14 were
associated with two events with opposite functional
signi¢cance: upregulation of the caspase-3 gene
which identi¢es cells committed to apoptosis [8],
and Bcl-2 overexpression which promotes cell surviv-
al. Thus the cell cycle and apoptosis genetic pro-
grams activated by pressure overload were intrinsi-
cally linked in the RV myocardium, but execution of
apoptosis was delayed until day 21 when the level of
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Bcl-2 collapsed. From a mechanistic point of view
the co-occurrence of the peak of catalytic activity
of the caspase-3 protease and of the drop of Bcl-2
suggests that this latter has eventually precipitated
apoptosis. The determinism of the triggering of apo-
ptosis, and of the striking biphasic change in Bcl-2
expression remains to be elucidated, although our
results point to potential contributing factors. The
onset of apoptosis at day 21 coincided with upregu-
lation of cyclin D1 (the G0 to S propellant cyclin,
barely detectable in the adult myocardium [9^11])
and downregulation of the cyclin-dependent kinases
inhibitor p27 (a major switch in the terminal di¡er-
entiation highly expressed in adult cardiomyocytes
[13]). It is noteworthy that cyclin D1 is an essential
mediator of neuronal apoptotic cell death [14,15],
and that upregulation of cyclins A/D1 and downre-
gulation of p27 have been reported to precede in vivo
apoptosis of neurons [16]. Therefore in both types of
post-mitotic terminally di¡erentiated cells a common
mechanism might cause apoptosis in response to ir-
regular cell cycle reentry and unbalance between mi-
togenic and di¡erentiation signals [17]. According to
this hypothesis, expression of p21 is likely to have
been upregulated at a late stage to block unscheduled
cell cycle progression [18]. With regard to this inter-
pretation some aspects of our model must be dis-
cussed. It is unclear why the caspase-3 activity
dropped at day 31. A similar discrepancy has been
reported recently in rat cardiomyocytes treated with
staurosporine [19]: activity of caspase-3 peaked at 4 h
at the onset of apoptosis, then sharply dropped
although the percentage of apoptotic cells steadily
increased until 24 h. On the contrary, in human
end stage cardiopathy the detection of a high level
of activated caspase-3 contrasted with the small
number of TUNEL positive nuclei [20]. Together
these observations are consistent with the recently
emerging view that apoptosis may follow an uncon-
ventional course in the myocardium [20]. Consider-
ing the extent of the changes in Bcl-2 expression
a¡ecting the entire myocardium, compared to the
rather low percentage (5^10%) of myocytes reacting
with anti-cyclin antibodies, it could be concluded
that irregular cell cycle reentry was not the major
triggering factor of apoptosis. However, the homoge-
neous heavy in situ labeling of cardiomyocytes by the
probes for the cyclins’ mRNA suggests that this per-
centage underestimates the actual extent of the cell
cycle reactivation phenomenon because of a lack of
sensitivity of the immunohistochemical technique,
and/or the high turnover of these proteins. In our
study the occurrence of extensive apoptosis detected
by the TUNEL assay is supported by the dramatic
downregulation of Bcl-2 and the activation of cas-
pase-3. It is noteworthy that in human arrhyth-
mogenic right ventricular dysplasia expression of
caspase-3 (CPP32) correlated with a high number
of TUNEL positive cardiomyocytes [21,22], suggest-
ing that the right ventricle is particularly susceptible
to the cell cycle and cell death signal triggered by
abnormal levels of resting tension. This hypothesis
is supported by the observation that in rat with
aortic banding or genetic hypertension, concentric
LV hypertrophy which bu¡ers the wall stress is as-
sociated with a minor response characterized by a
transient early peak of apoptosis and no expression
of cyclin A, E or D1 [23,24]. Therefore the patholog-
ical e¡ects of pressure overload depend on the
chamber-speci¢c myocyte phenotype. In this regard,
it is noteworthy that in the human left ventricle
DNA synthesis and apoptosis have been detected at
the decompensated, end stage of hypertrophy, when
the dilated LV became unable to cope with the wall
stress [25]. Expression of the Fas gene, upregulation
of AT1, activation of p53, and decrease in the Bcl-2 to
Bax protein ratio have been reported to mediate ap-
optosis in isolated cardiomyocytes by overstretching
[5,26]. Our results did not con¢rm the involvement of
the AT1-p53-Fas pathway in the in vivo pressure-in-
duced RVH: no change in the AT1 receptor mRNA
level could be detected and immunohistochemistry
failed to identify the p53, Bax or Fas protein. There-
fore, the cell death scheme designed from data ob-
tained in experimental systems cannot be extended
to the in vivo RV pressure overload conditions. In
summary, these results provide correlative evidence
that the apoptotic and hyperplastic gene programs
are selectively and extensively co-activated in the right
ventricle subjected to pressure overload, and that
these changes in synergy with disruption of the cy-
toarchitecture contribute to the irreversible impair-
ment of the contractile function. They suggest that
overexpression of Bcl-2 may play a critical role in
preventing the execution of apoptosis until the tran-
sition stage to ventricular failure.
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